Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03XLX
|
|||
| Former ID |
DIB002016
|
|||
| Drug Name |
CP-778875
|
|||
| Synonyms |
Dyslipidemia therapy, Pfizer; CP-778,875
Click to Show/Hide
|
|||
| Indication | Lipid metabolism disorder [ICD-11: 5C52.Z] | Phase 2 | [1] | |
| Company |
Pfizer Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00326326) Effect of CP-778,875 on HDL-C in Subjects With Abnormal Lipid Levels and Type 2 Diabetes.. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.